197 related articles for article (PubMed ID: 30187332)
1. Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative Chemotherapy.
Swords DS; Francis SR; Lloyd S; Garrido-Laguna I; Mulvihill SJ; Gruhl JD; Christensen MC; Stoddard GJ; Firpo MA; Scaife CL
J Gastrointest Surg; 2019 Jul; 23(7):1401-1413. PubMed ID: 30187332
[TBL] [Abstract][Full Text] [Related]
2. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy.
Roland CL; Katz MH; Tzeng CW; Lin H; Varadhachary GR; Shroff R; Javle M; Fogelman D; Wolff RA; Vauthey JN; Crane CH; Lee JE; Fleming JB
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1221-8. PubMed ID: 26350371
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.
Zheng ZJ; Wang MJ; Tan CL; Chen YH; Ping J; Liu XB
Medicine (Baltimore); 2020 Feb; 99(8):e19327. PubMed ID: 32080152
[TBL] [Abstract][Full Text] [Related]
4. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.
Showalter TN; Winter KA; Berger AC; Regine WF; Abrams RA; Safran H; Hoffman JP; Benson AB; MacDonald JS; Willett CG
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1328-35. PubMed ID: 20934270
[TBL] [Abstract][Full Text] [Related]
5. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.
Bhatti I; Peacock O; Awan AK; Semeraro D; Larvin M; Hall RI
World J Surg; 2010 Apr; 34(4):768-75. PubMed ID: 20052471
[TBL] [Abstract][Full Text] [Related]
7. The effect of preoperative treatments on lymph node counts after total gastrectomy in esophagogastric adenocarcinoma.
Li Z; Li S; Bu Z; Zhang L; Wu X; Shan F; Jia Y; Ji X; Ji J
J Surg Oncol; 2018 Sep; 118(4):657-663. PubMed ID: 30196579
[TBL] [Abstract][Full Text] [Related]
8. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
Estrella JS; Rashid A; Fleming JB; Katz MH; Lee JE; Wolf RA; Varadhachary GR; Pisters PW; Abdalla EK; Vauthey JN; Wang H; Gomez HF; Evans DB; Abbruzzese JL; Wang H
Cancer; 2012 Jan; 118(1):268-77. PubMed ID: 21735446
[TBL] [Abstract][Full Text] [Related]
9. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
[TBL] [Abstract][Full Text] [Related]
10. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
[TBL] [Abstract][Full Text] [Related]
11. The impact of chemotherapy sequencing on resectable pancreatic cancer by stage.
Vega EA; Kutlu OC; Salehi O; Alarcon SV; Abudalou M; Kozyreva O; Krishnan S; Lee D; Freeman R; Conrad C
Surg Oncol; 2022 Mar; 40():101694. PubMed ID: 34973593
[TBL] [Abstract][Full Text] [Related]
12. The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Anticancer Res; 2018 Aug; 38(8):4877-4882. PubMed ID: 30061263
[TBL] [Abstract][Full Text] [Related]
13. Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?
He J; Blair AB; Groot VP; Javed AA; Burkhart RA; Gemenetzis G; Hruban RH; Waters KM; Poling J; Zheng L; Laheru D; Herman JM; Makary MA; Weiss MJ; Cameron JL; Wolfgang CL
Ann Surg; 2018 Jul; 268(1):1-8. PubMed ID: 29334562
[TBL] [Abstract][Full Text] [Related]
14. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
15. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
16. [Surgical therapy of pancreatic cancer - 5 years survival].
Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
[TBL] [Abstract][Full Text] [Related]
17. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.
Fischer LK; Katz MH; Lee SM; Liu L; Wang H; Varadhachary GR; Wolff RA; Lee JE; Maitra A; Roland CL; Fleming JB; Estrella J; Rashid A; Wang H
Histopathology; 2016 Jan; 68(2):210-20. PubMed ID: 25945396
[TBL] [Abstract][Full Text] [Related]
18. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
19. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
20. The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis.
Amin S; Baine M; Meza J; Lin C
BMC Cancer; 2020 Jun; 20(1):538. PubMed ID: 32517661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
